Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 15;28(22):115784.
doi: 10.1016/j.bmc.2020.115784. Epub 2020 Sep 24.

Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis

Affiliations

Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis

Guo-Liang Lu et al. Bioorg Med Chem. .

Abstract

A series of 5,8-disubstituted tetrahydroisoquinolines were shown to be effective inhibitors of M. tb in culture and modest inhibitors of M. tb ATP synthase. There was a broad general trend of improved potency with higher lipophilicity. Large substituents (e.g., Bn) at the tetrahydroquinoline 5-position were well-tolerated, while N-methylpiperazine was the preferred 8-substituent. Structure-activity relationships for 7-linked side chains showed that the nature of the 7-linking group was important; -CO- and -COCH2- linkers were less effective than -CH2- or -CONH- ones. This suggests that the positioning of a terminal aromatic ring is important for target binding. Selected compounds showed much faster rates of microsomal clearance than did the clinical ATP synthase inhibitor bedaquiline, and modest inhibition of mycobacterial ATP synthase.

Keywords: ATP synthase; Structure-activity relationships; Synthesis; Tetrahydroquinolines; Tuberculosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Examples of bioactive N-substituted tetrahydroisoquinolines.
Scheme 1
Scheme 1
Syntheses of 5-substituted tetrahydroisoquinoline intermediates.
Scheme 2
Scheme 2
Syntheses of the tetrahydroisoquinolines 6–17 of Table 1.
Scheme 2
Scheme 2
Syntheses of the tetrahydroisoquinolines 6–17 of Table 1.
Scheme 3
Scheme 3
Synthesis of CO-linked compounds 18–22 of Table 1.
Scheme 4
Scheme 4
Synthesis of CONH-linked compounds 23–42 of Table 1.
Scheme 5
Scheme 5
Synthesis of –COCH2-linked compounds 43–47 of Table 1.
Scheme 6
Scheme 6
Synthesis of –CO-linked non-aromatic sidechain compounds 48–51 of Table 1.
Scheme 7
Scheme 7
Syntheses of the tetrahydroisoquinolines 52–55 of Table 2.

References

    1. WHO Global Tuberculosis Report 2019 (https://www.who.int/tb/publications/global_report/en/): accessed 2nd July 2020.
    1. Andries K., Verhasselt P., Guillemont J. Science. 2005;307:223–227. doi: 10.1517/13543784.14.7.917. - DOI - PubMed
    1. Pym A.S., Diacon A.H., Tang S.J., Conradie F. On behalf of the TMC207-C209 study group. Eur. Respir. J. 2016;47:564–574. - PubMed
    1. Global Alliance for TB Drug Development website (https://www.tballiance.org/portfolio/compound/tbaj-876-diarylquinoline); accessed 2nd July 2020.
    1. Sutherland H.S., Tong A.S.T., Choi P.J. 3,5-Dialkoxypyridine analogs of bedaquiline are potent antitubercular agents with minimal inhibition of the hERG channel. Bioorg Med Chem. 2019;27:1292–1307. doi: 10.1016/j.bmc.2019.02.026. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources